Cytokine & Growth Factor Reviews

Papers
(The TQCC of Cytokine & Growth Factor Reviews is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Editorial Board140
Unveiling cytokine charge disparity as a potential mechanism for immune regulation136
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions116
Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics109
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon105
Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases93
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs89
COVID-19: From emerging variants to vaccination77
Editorial Board72
Editorial Board71
Editorial Board68
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism65
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy64
Participation of interferons in psoriatic inflammation62
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects62
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances61
Gradients in the in vivo intestinal stem cell compartment and their in vitro recapitulation in mimetic platforms58
Molecular mechanisms of regulation of IL-1 and its receptors57
Epithelial-to-mesenchymal transition transcription factors: New strategies for mesenchymal tissue regeneration54
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection51
The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment50
Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation49
Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets48
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer47
Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence44
Exogenous drug-induced mouse models of atopic dermatitis44
TGF-β mediated drug resistance in solid cancer43
Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis42
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review42
Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles42
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis40
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-237
Principles of the activin receptor signaling pathway and its inhibition37
The cGAS-STING pathway: Post-translational modifications and functional implications in diseases36
Neurotrophic factors and their receptors in lung development and implications in lung diseases35
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells35
Exosomes as a modulator of immune resistance in human cancers35
COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling34
Multifaceted role of CD14 in innate immunity and tissue homeostasis34
MDSCs might be “Achilles heel” for eradicating CSCs33
Decoding the roles of heat shock proteins in liver cancer31
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?31
Editorial Board31
The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential31
B cell-activating factor and its targeted therapy in autoimmune diseases30
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies30
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases29
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands29
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment28
Netrin-1: An emerging player in inflammatory diseases28
The impact of adipokines on vascular networks in adipose tissue27
Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights27
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy27
Chemokine networks modulating natural killer cell trafficking to solid tumors26
Forgetting COVID-19 – Introduction to the special issue26
Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities25
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance25
Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation24
Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer24
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease24
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism23
mTOR in programmed cell death and its therapeutic implications23
0.048441886901855